Technical Analysis for CGS - CogState Limited  

Grade Last Price % Change Price Change
D 1.250 1.21% 0.015
CGS closed up 1.21 percent on Tuesday, May 14, 2024, on 26 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness 1.21%
Lower Bollinger Band Touch Weakness 1.21%
Fell Below 20 DMA Bearish -2.34%
Fell Below 50 DMA Bearish -2.34%
MACD Bearish Signal Line Cross Bearish -2.34%
New Downtrend Bearish -2.34%
Earnings Movers Other -2.34%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago
Down 3% about 18 hours ago
Down 2% about 18 hours ago
Down 1% about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CogState Limited   Description

Cogstate Limited is a cognitive science company delivering software and services. The Company's segments include cognitive testing in Clinical Trials; the precision recruitment market, the healthcare market, the sport market and administration. In the clinical trials market, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the precision recruitment market, the technology is used as an online screening tool as part of the process of recruiting subjects in clinical trials. In the healthcare market, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. In the sport market, the technology and associated services are used to provide concussion management tools in sport.


Classification

Sector: Technology
Industry: Health Information Services
Keywords: Health Software Healthcare Pharmaceutical Biotechnology Disease Drugs Clinical Trial Recruitment Pharmaceutical Industry Drug Discovery Screening Biotechnology Companies Healthcare Market Primary Care Clinical Research Concussion

Is CGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.87
52 Week Low 1.125
Average Volume 79,076
200-Day Moving Average 1.383
50-Day Moving Average 1.293
20-Day Moving Average 1.332
10-Day Moving Average 1.352
Average True Range 0.052
RSI (14) 40.83
ADX 31.05
+DI 23.977
-DI 38.941
Chandelier Exit (Long, 3 ATRs) 1.285
Chandelier Exit (Short, 3 ATRs) 1.350
Upper Bollinger Bands 1.460
Lower Bollinger Band 1.205
Percent B (%b) 0.18
BandWidth 19.185
MACD Line 0.003
MACD Signal Line 0.020
MACD Histogram -0.0173
Fundamentals Value
Market Cap 212.67 Million
Num Shares 170 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -59.52
Price-to-Sales 4.50
Price-to-Book 7.06
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.333
Resistance 3 (R3) 1.323 1.287 1.319
Resistance 2 (R2) 1.287 1.266 1.291 1.314
Resistance 1 (R1) 1.268 1.253 1.278 1.278 1.310
Pivot Point 1.232 1.232 1.236 1.236 1.232
Support 1 (S1) 1.213 1.211 1.223 1.223 1.190
Support 2 (S2) 1.177 1.198 1.181 1.186
Support 3 (S3) 1.158 1.177 1.181
Support 4 (S4) 1.168